Enright William 4
4 · Altimmune, Inc. · Filed Aug 18, 2017
Insider Transaction Report
Form 4
Enright William
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Stock Options (option to buy)
2017-08-16−71,644→ 0 totalExercise: $0.08From: 2017-05-04Exp: 2019-12-31→ Common Stock (71,644 underlying) - Exercise/Conversion
Stock Options (option to buy)
2017-08-16−91,733→ 0 totalExercise: $0.08From: 2017-05-04Exp: 2021-12-03→ Common Stock (91,733 underlying) - Exercise/Conversion
Common Stock
2017-08-16$0.08/sh+71,644$5,732→ 89,431 total - Exercise/Conversion
Common Stock
2017-08-16$0.08/sh+91,733$7,339→ 181,164 total